MedKoo Cat#: 461279 | Name: RGH 1756

Description:

WARNING: This product is for research use only, not for human or veterinary use.

RGH 1756 is an atypical antipsychotic with high affinity to dopamine D(3) receptors that results in a unique pattern of c-Fos induction.

Chemical Structure

RGH 1756
RGH 1756
CAS#207277-37-0

Theoretical Analysis

MedKoo Cat#: 461279

Name: RGH 1756

CAS#: 207277-37-0

Chemical Formula: C26H30N4O2S

Exact Mass: 462.2089

Molecular Weight: 462.61

Elemental Analysis: C, 67.50; H, 6.54; N, 12.11; O, 6.92; S, 6.93

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
RGH 1756; RGH-1756;
IUPAC/Chemical Name
6-(4-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butoxy)phenyl)imidazo[2,1-b]thiazole
InChi Key
XFCPMLXQURUUPM-UHFFFAOYSA-N
InChi Code
InChI=1S/C26H30N4O2S/c1-31-25-7-3-2-6-24(25)29-15-13-28(14-16-29)12-4-5-18-32-22-10-8-21(9-11-22)23-20-30-17-19-33-26(30)27-23/h2-3,6-11,17,19-20H,4-5,12-16,18H2,1H3
SMILES Code
COC1=CC=CC=C1N2CCN(CCCCOC3=CC=C(C4=CN5C(SC=C5)=N4)C=C3)CC2
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 462.61 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Gémesi LI, Kapás M, Szeberényi S. Application of LC-MS analysis to the characterisation of the in vitro and in vivo metabolite profiles of RGH-1756 in the rat. J Pharm Biomed Anal. 2001 Mar;24(5-6):877-85. PubMed PMID: 11248481. 2: Kovács KJ, Csejtei M, Laszlovszky I. Double activity imaging reveals distinct cellular targets of haloperidol, clozapine and dopamine D(3) receptor selective RGH-1756. Neuropharmacology. 2001 Mar;40(3):383-93. PubMed PMID: 11166331. 3: Sóvágó J, Farde L, Halldin C, Schukin E, Schou M, Laszlovszky I, Kiss B, Gulyás B. Lack of effect of reserpine-induced dopamine depletion on the binding of the dopamine-D3 selective radioligand, [11C]RGH-1756. Brain Res Bull. 2005 Oct 15;67(3):219-24. PubMed PMID: 16144658. 4: Terjéki E, Kapás M. An HPLC/UV method for the determination of RGH-1756 in dog and rat plasma. J Pharm Biomed Anal. 2001 Mar;24(5-6):913-20. PubMed PMID: 11248484. 5: Sóvágó J, Farde L, Halldin C, Langer O, Laszlovszky I, Kiss B, Gulyás B. Positron emission tomographic evaluation of the putative dopamine-D3 receptor ligand, [11C]RGH-1756 in the monkey brain. Neurochem Int. 2004 Oct;45(5):609-17. PubMed PMID: 15234102.